Montelukast Prescribing at WHITE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,235
Total Quantity
28.0K
NHS Cost
£1.4K
vs National Avg
+80.4%
WHITE HOUSE SURGERY prescribed 1,235 items of Montelukast over the last 12 months at a cost of £1,356 to the NHS. This is 80.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
111
Jul 2026
116
Jul 2026
96
Jul 2026
108
Jul 2026
94
Jul 2026
104
Jul 2026
101
Jul 2026
96
Jul 2026
112
Jul 2026
87
Jul 2026
96
Jul 2026
114
Prescribing Details
| Total Items | 1,235 |
|---|---|
| Total Quantity | 27,979 |
| Total NHS Cost | £1,356 |
| Presentations | 4 different forms |
| vs National Average | +80.4% |
Montelukast Prescribing Comparison
| This practice | 1,235 items |
|---|---|
| National average per practice | 685 items |
| Difference | +80.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.